Effects of Fish Oils on Inflammation and Insulin Resistance

Completed · Not applicable · Has a placebo group

Conditions studied: Metabolic Syndrome, Insulin Resistance

In brief

The purpose of this study is to determine whether improvement in fat and muscle metabolism after the treatment with Omacor (fish oils) provides insight into the link between obesity, fat and muscle function leading to metabolic syndrome, which is a risk factor for heart disease and diabetes.

Key facts

Study ID

NCT00579436

Run by

Philip Kern

People needed

33

Starts

2007-01-01

Expected to finish

2015-01-15

Last updated by the study team

2018-05-16

Who can join

Age: 35 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• BMI 27-45 kg/m2
• age 35-65 years
• abnormal carbohydrate metabolism

You may not qualify if…

• triglycerides over 700 mg/dl
• renal disease
• liver disease
• congestive heart failure
• history of heart disease or stroke
• chronic aspirin or NSAID use (anti-coagulant)
• history of a bleeding disorder
• use of statins, fibrates, ACE inhibitors, angiotensin II receptor blockers and glucocorticoids
• diet heavy in omega-3 fatty acids (salmon, sardines, flaxseeds)

Where it is running

• University of Kentucky Medical Cener — Lexington, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.